Search Results - "Unamunzaga‐Cilaurren, Ariane"
-
1
Velcadito: Low dose of bortezomib with melphalan and prednisone for ≥75‐year‐olds newly diagnosed with multiple myeloma
Published in European journal of haematology (01-06-2022)Get full text
Journal Article -
2
Treatment burden in multiple myeloma according to comorbidity in real life
Published in Annals of hematology (01-02-2022)Get full text
Journal Article -
3
PB2701: SAFETY OF 30 MINUTES INFUSION OF RITUXIMAB BIOSIMILAR. A COHORT STUDY
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
4
Ultrafast 30-min infusion of a rituximab biosimilar (Truxima)
Published in EJHaem (01-11-2023)“…In this clinical trial, we demonstrate that ultrarapid fast infusion of rituximab (Truxima) in 30 min with oral premedication is feasible and secure for…”
Get full text
Journal Article -
5
Txagorrapid: Ultrarapid infusion in 30 minutes of the biosimilar of rituximab truxima—A cohort study
Published in Journal of clinical oncology (01-06-2022)“…e13638 Background: Rituximab (anti-CD20 Ab) is the cornerstone of the treatment of non-Hodgkin B lymphomas. Infusion-related reactions (IRR) are the most…”
Get full text
Journal Article -
6
Treatment Burden in Patients with Multiple Myeloma According to Comorbidity
Published in Blood (29-11-2018)“…▪ Introduction: Over the last few years, novel agents-based combinations have been incorporated into the treatment of MM patients, particularly in relapse…”
Get full text
Journal Article